The stock has been placed in Graded Surveillance Measure (GSM) list GSM - 0.

Roselabs Finance Ltd.

BSE: 531324

Sector: Financial Services

Industry Group: Finance

Industry: Other Financial Services

20.50+0.0 (+0.00%)

21 Aug, 12:00 AM

Income Statement

Abridged

Understanding Income Statement

Roselabs Finance Ltd. income statement covering revenue, operating profit, EBITDA, PAT and EPS across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31	TTM Jun 30
	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31	TTM Jun 30
Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M IR
Total Revenue	0.16	-	0.15	1.18	0.73	1.21	1.21
Cost of Operating Revenue	-	-	-	1.13	0.70	1.20	-
Total Operating Expenses	0.16	0.44	0.69	1.31	1.02	1.41	1.41
Operating Profit	0.01	-0.44	-0.54	-0.13	-0.29	-0.20	-0.21
Operating Margin	4.3	-	-359.0	-11.2	-40.2	-16.4	-17.0
Profit before Taxes	-2.75	-0.44	2.06	-0.13	-0.29	-0.20	-0.21
Income Taxes	-0.17	0.00	0.05	-	-	-0.11	-0.11
Profit after Tax	-2.57	-0.44	2.02	-0.13	-0.29	-	-0.31
PAT Margin	-1,565.9	-	1,336.8	-11.2	-40.2	-	-26.1
EPS - Basic - ex Extraordinary Items	-2.57	-0.44	2.02	-0.13	-0.29	-	-0.31
EPS - Diluted - ex Extraordinary Items	-2.57	-0.44	2.02	-0.13	-0.29	-0.31	-0.33
EBIT	0.01	-0.44	-0.54	-0.13	-0.29	-0.20	-0.21
EBITDA	0.01	-0.44	-0.54	-0.13	-0.29	-	-0.21
EBITDA Margin	4.3	-	-359.0	-11.2	-40.2	-	-17.0

Balance Sheet

Abridged

Understanding Balance Sheet

Roselabs Finance Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
Source:	AR	AR	AR	AR	AR	AR
Total Assets	0.20	0.18	0.11	1.52	0.23	0.06
Long Term Debt	-	4.93	4.33	4.57	4.93	5.07
Total Liabilities	6.09	6.50	4.42	5.95	4.95	5.09
Total Shareholders' Equity	-5.88	-6.32	-4.30	-4.44	-4.73	-5.03
Total Equity	-5.88	-6.32	-4.30	-4.44	-4.73	-5.03
Total Liabilities & Equity	0.20	0.18	0.11	1.52	0.23	0.06
Total Current Assets	0.05	0.03	0.00	1.41	0.12	0.06
Total Current Liabilities	6.09	1.58	0.09	1.39	0.02	0.02

Cash Flow

Abridged

Understanding Cash Flow Statement

Roselabs Finance Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR
Operating CF bef Changes in Working Cap	-0.16	0.06	1.99	-0.16	-0.31	-0.20
Working Capital - Increase/(Decrease)	-0.04	-0.06	-1.41	-0.01	-0.01	-0.01
Net CF from Operating Activities	-0.20	-	0.58	-0.18	-0.32	-0.20
Net CF from Investing Activities	0.16	-	-	-	-	-
Debt - LT & ST - Issuance/(Retirement) - Total	0.07	-0.36	-0.60	0.24	0.37	0.14
Net Cash Flow from Financing Activities	0.07	-	-0.60	0.24	0.37	0.14
Free Cash Flow to Equity	-0.12	-0.36	-0.02	0.06	0.05	-0.06
Free Operating CF net dividend	-0.20	-	0.58	-0.18	-0.32	-
Free Operating CF	-0.20	-	0.58	-0.18	-0.32	-

Business Segment Analysis

Roselabs Finance Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

We don't have enough data to show business segment analysis for Roselabs Finance Ltd.

Regional Segment Analysis

Roselabs Finance Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

We don't have enough data to show regional segment analysis for Roselabs Finance Ltd.

Historical Segment Analysis

Track how Roselabs Finance Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

We don't have enough data to show segments for Roselabs Finance Ltd.

Frequently Asked Questions

What is the revenue of Roselabs Finance Ltd.?

The latest trailing twelve month revenue of Roselabs Finance Ltd. is ₹ 1.21 Cr, reflecting a 1-year growth of 66.35% and a 3-year CAGR of 100.06%. Annual and quarterly revenue trends are available in the Income Statement section.

What is the net profit of Roselabs Finance Ltd.?

The latest trailing twelve month net profit (PAT) of Roselabs Finance Ltd. is ₹ -0.31 Cr, with a 3-year earnings CAGR of -29.05%. Detailed profit history across annual and quarterly periods is in the Income Statement section.

What is the EBITDA of Roselabs Finance Ltd.?

The trailing twelve month EBITDA of Roselabs Finance Ltd. is approximately ₹ -0.21 Cr (based on an operating margin of -17.04%). EBITDA reflects core operating profitability before interest, taxes, depreciation and amortisation.

What is the EPS of Roselabs Finance Ltd.?

The trailing twelve month Earnings Per Share (EPS) of Roselabs Finance Ltd. is -0.31. EPS trends across annual and quarterly periods are visible in the Income Statement section.

What is the debt level of Roselabs Finance Ltd.?

The debt-to-equity ratio of Roselabs Finance Ltd. stands at -. The full breakdown of total borrowings is in the Balance Sheet section.

What is the book value per share of Roselabs Finance Ltd.?

The book value per share of Roselabs Finance Ltd. is available in the Balance Sheet section of the Statements tab.

What is the cash flow from operations of Roselabs Finance Ltd.?

The trailing twelve month operating cash flow of Roselabs Finance Ltd. is ₹ -0.20 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.

Does Roselabs Finance Ltd. report consolidated or standalone financials?

Roselabs Finance Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.